21st Jan 2005 10:06
SR Pharma plc ("the Company") Extraordinary General Meeting London, UK 20 January 2005 - the Company announced, on 19 November 2004, thatpursuant to its search for a suitable acquisition or merger it was in latestage talks with one potential acquisition target. Those talks have progressedto the satisfaction of the Company and the Company wishes to facilitate theongoing discussions and to ensure that the Directors have the flexibility toagree the terms of any proposed acquisition including the issue of shares bythe Company.Accordingly, the Company has convened an extraordinary general meeting of theCompany to be held on 4 February 2005. At this meeting, an ordinary resolutionwill be proposed to grant the Directors authority to allot relevant securitieswithin the meaning of Section 80 of the Companies Act 1985, for a periodexpiring on 31 December 2005 up to an aggregate nominal value of ‚£230,000representing 96.29 per cent of the current issued share capital of the Company.A copy of the circular to shareholders convening the meeting will be availableat the offices of the Company, 26th Floor, Centre Point, 103 New Oxford Street,London WC1A 1DD, until 20 February 2005.For further information please contact:Iain RossChairmanSR Pharma plcTel: +44 (0) 20 7307 1620ENDRelated Shares:
SLN.L